Abstract
Burkholderia pseudomallei is the causative agent of melioidosis, endemic in Southeast Asia and Northern Australia, and increasingly recognized in southern China, especially in Hainan Province. Mycotic aneurysm caused by B. pseudomallei is a rare but potentially severe illness with a high mortality rate. The clinical features of the mycotic aneurysm secondary to melioidosis have not been illustrated in China. Over a seven-year period (2013 to 2019), 159 patients with bacteremic melioidosis were retrospectively analyzed in Hainan province, China, of whom eight patients were confirmed to have mycotic aneurysm through the combination of imaging examination, pathologic examination and aneurysm tissue culture. We summarized these eight patients’ clinical characteristics, demographical features, treatments and outcomes. The susceptibilities to five commonly-used antibiotics for these eight B. pseudomallei isolates were also determined by E-test strips. Furthermore, the mycotic aneurysm cases secondary to melioidosis retrieved from the literature were also reviewed. Of the eight cases, six had abdominal mycotic aneurysms, one had a left iliac aneurysm, and the other one had an infectious mesenteric aneurysm. They were aged from 48 to 69 years old, and had the underlying risk factors of diabetes mellitus (2 patients), long-term smoking (4 patients), hypertension (6 patients), and soil and water contact history (6 patients), respectively. The positive arterial aneurysm imaging was observed in all patients via computed tomography (CT) or angiography. Eight B. pseudomallei isolates collected from both blood and mycotic aneurysm tissues remained 100% susceptible to imipenem and ceftazidime. After surgery combined with antibiotic administration, six patients survived, with a mortality rate of 25%. In melioidosis endemic areas, the mycotic aneurysm secondary to melioidosis might be underdiagnosed, and increased awareness of predisposing risk factors and clinical features of the mycotic aneurysm is required. Following a positive B. pseudomallei blood culture, the diagnosis of mycotic aneurysm should be under consideration in those with abdominal pain and/or hypertension. Imaging by CT or angiography is indispensable for its timely diagnosis and management.
Highlights
Burkholderia pseudomallei is an aerobic Gram-negative, invasive bacillus, found in soil and stagnant water in tropical regions, and predominantly endemic to Southeast Asia and Australia [1,2,3,4]
In melioidosis endemic areas, or for those returning from endemic areas, increased awareness of the risk factors is required for early diagnosis and management of mycotic aneurysm secondary to melioidosis
Pneumonia was the most frequent clinical manifestation (58/159, 36.5%), but the patients did show a wide spectrum of clinical features, including soft tissue infection (35/159, 22%), genitourinary infection (29/159, 18.2%), and internal organ abscesses (16/159, 10.1%)
Summary
Burkholderia pseudomallei is an aerobic Gram-negative, invasive bacillus, found in soil and stagnant water in tropical regions, and predominantly endemic to Southeast Asia and Australia [1,2,3,4]. Melioidosis, transmitted via percutaneous inoculation and inhalation of soil or water containing B. pseudomallei in the environment, is a potentially fatal infection, manifesting as acute, subacute, or chronic disease [5]. Those in regular contact with contaminated soil and water are most commonly affected [2]. Mainly aortic aneurysm, is an irreversible dilatation of an artery and a rare complication, of which the most frequent pathogens are Salmonella species and Staphylococcus aureus; it can be caused by B. pseudomallei [4, 6, 7]. It is estimated that approximately 0.4% ~7.5% melioidosis patients have a mycotic aneurysm [11, 13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.